Coronary In-stent Restenosis Clinical Trial
Official title:
Prospective Study of Bioresorbable Vascular Scaffold Treatment in Patients With In-stent Restenosis
Treatment of patients with in-stent restenosis (ISR) remains a challenge. This study will assess the efficacy of Bioresorbable Vascular Scaffolds (BVS) (Abbott Vascular) in the treatment of patients suffering from ISR.
Treatment of patients with ISR remains a challenge. Currently both drug-eluting stents (DES)
and drug-coated balloons (DCB) are considered as the strategies of choice in this setting.
However, data on the value of BVS in patients with ISR is scarce. BVS are very effective to
inhibit neointimal proliferation and they avoid the need of implanting a new permanent metal
layer. Accordingly, currently, there is a major interest to elucidate the potential value of
BVS in patients with ISR.
This prospective Spanish multicenter study will assess the clinical and angiographic outcome
of patients with ISR treated with BVS. BVS will be implanted in selected patients
(fulfilling inclusion and exclusion criteria) presenting with either BMS-ISR or DES-ISR.
Care will be paid to ensure device optimization. Angiographic follow-up will be obtained at
6-9 months. A centralized angiographic corelab will be used to provide QCA measurements.
Clinical follow-up will be also obtained at 1 year and then yearly. Clinical events will be
adjudicated by an independent Clinical Event Committee.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT00852176 -
Retrospective Long-term Safety and Efficacy Study of the Beta-Cath(TM) 3.5F System
|
||
Recruiting |
NCT03069066 -
Restenosis Intrastent: Bioresorbable Vascular Scaffolds Treatment With Scoring Balloon Pre-dilatation (RIBS VI Scoring)
|
Phase 4 | |
Recruiting |
NCT04213378 -
Evaluation of the Efficacy and Safety of a Paclitaxel Eluting PTCA Balloon Catheter in Coronary In-stent Restenosis
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT03373695 -
A Safety and Efficacy Study of Dissolveā¢ in Treatment of Coronary In-stent Restenosis
|
N/A |